Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs

Clinical and Experimental Vaccine Research

Volumn 7, Issue 1, 2018, Pages 61-69

  Lee, Seung Heon ^a   Yang, Dong Kun ^a   Kim, Ha Hyun ^a   Cho, In Soo ^a  

^a Ministry of Agriculture and Forestry Korea   (South Korea)

Author keywords

Adjuvant; Growing pigs; Porcine epidemic diarrhea virus; Vaccines

Indexed keywords

AMINO ACID; IMMUNOLOGICAL ADJUVANT; INACTIVATED VIRUS VACCINE; PORCINE EPIDEMIC DIARRHEA VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; WATER OIL CREAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; IMMUNE RESPONSE; NONHUMAN; PORCINE EPIDEMIC DIARRHEA; PORCINE EPIDEMIC DIARRHEA VIRUS; PRIORITY JOURNAL; VACCINATION; VERO CELL LINE; VIRUS CULTURE; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS MUTATION; VIRUS NEUTRALIZATION; VIRUS SHEDDING; VIRUS STRAIN;

EID: 85044170477     PISSN: 22873651     EISSN: 2287366X     Source Type: Journal    
DOI: 10.7774/cevr.2018.7.1.61     Document Type: Article

References (35)

1. Debouck P, Pensaert M. Experimental infection of pigs with a new porcine enteric coronavirus, CV 777. Am J Vet Res 1980;41:219-23.
2. Pensaert MB, Yeo SG. Porcine epidemic diarrhea. In: Straw BE, Zimmerman JJ, D’Allaire S, Taylor DJ, editors. Disease of swine. 9th ed. Ames, IW: Blackwell Publishing; 2006. p.367-72.
3. Pijpers A, van Nieuwstadt AP, Terpstra C, Verheijden JH. Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet Rec 1993;132:129-31.
4. Oldham J. Letter to the editor. Pig Farming 1972;10:72-3.
5. Pensaert MB, de Bouck P. A new coronavirus-like particle associated with diarrhea in swine. Arch Virol 1978;58:243-7.
6. Lee C. Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus. Virol J 2015;12:193.
7. Song DS, Oh JS, Kang BK, et al. Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain. Res Vet Sci 2007;82:134-40.
8. Saif LJ, Pensaert MP, Sestak K, Yeo SG, Jung K. Coronavi-ruses. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of swine. 10th ed. Ames, IW: Wiley-Blackwell; 2012. p.501-24.
9. Song D, Park B. Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes 2012;44:167-75.
10. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003;77:8801-11.
11. Chang SH, Bae JL, Kang TJ, et al. Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. Mol Cells 2002;14:295-9.
12. Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001;279:371-4.
13. Sato T, Takeyama N, Katsumata A, Tuchiya K, Kodama T, Kusanagi K. Mutations in the spike gene of porcine epidemic diarrhea virus associated with growth adaptation in vitro and attenuation of virulence in vivo. Virus Genes 2011;43:72-8.
14. Lee S, Lee C. Outbreak-related porcine epidemic diarrhea virus strains similar to US strains, South Korea, 2013. Emerg Infect Dis 2014;20:1223-6.
15. Park BK, Song D. Recent outbreaks and emergence of mutants of porcine epidemic diarrhea viruses (PEDV) in Korea. Jpn J Vet Res 2016;64(Suppl 1):S25-32.
16. Lee DK, Park CK, Kim SH, Lee C. Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea. Virus Res 2010;149:175-82.
17. Yang DK, Kim HH, Lee SH, Yoon SS, Park JW, Cho IS. Isolation and characterization of a new porcine epidemic diarrhea virus variant that occurred in Korea in 2014. J Vet Sci 2017 Jul 10 [Epub].
18. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.
19. Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res 2014;42:W320-4.
20. Song D, Moon H, Kang B. Porcine epidemic diarrhea: a review of current epidemiology and available vaccines. Clin Exp Vaccine Res 2015;4:166-76.
21. Liu S, Xiao L, Nelson C, Hagedorn CH. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses. PLoS One 2012;7:e44965.
22. Daemer RJ, Feinstone SM, Gust ID, Purcell RH. Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun 1981;32:388-93.
23. Collin EA, Anbalagan S, Okda F, Batman R, Nelson E, Hause BM. An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration. BMC Vet Res 2015; 11:62.
24. Thiel V, Herold J, Schelle B, Siddell SG. Viral replicase gene products suffice for coronavirus discontinuous transcription. J Virol 2001;75:6676-81.
25. Xing N, Guan X, An B, et al. Ultrasensitive detection of porcine epidemic diarrhea virus from fecal samples using func-tionalized nanoparticles. PLoS One 2016;11:e0167325.
26. Goede D, Murtaugh MP, Nerem J, Yeske P, Rossow K, Morrison R. Previous infection of sows with a “mild” strain of porcine epidemic diarrhea virus confers protection against infection with a “severe” strain. Vet Microbiol 2015;176: 161-4.
27. Park ME, Lee SY, Kim RH, et al. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats. Vaccine 2014;32:5221-7.
28. Comi G, Freedman MS, Kappos L, et al. Pooled safety and tolerability data from four placebo-controlled terifluno-mide studies and extensions. Mult Scler Relat Disord 2016; 5:97-104.
29. Ibrahim Eel S, Gamal WM, Hassan AI, Mahdy Sel D, Hega-zy AZ, Abdel-Atty MM. Comparative study on the immu-nopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. Vet World 2015; 8:1189-98.
30. Bouguyon E, Goncalves E, Shevtsov A, et al. A new adju- vant combined with inactivated influenza enhances specific CD8 T cell response in mice and decreases symptoms in swine upon challenge. Viral Immunol 2015;28:524-31.
31. Aziz-Boaron O, Gleser D, Yadin H, et al. The protective effectiveness of an inactivated bovine ephemeral fever virus vaccine. Vet Microbiol 2014;173:1-8.
32. Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19:2666-72.
33. Jang SI, Lillehoj HS, Lee SH, et al. Mucosal immunity against Eimeria acervulina infection in broiler chickens following oral immunization with profilin in Montanide adjuvants. Exp Parasitol 2011;129:36-41.
34. Walders B, Raschke A, Neugebauer M, et al. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component. Res Vet Sci 2005;78:135-41.
35. Deville S, Arous JB, Bertrand F, Borisov V, Dupuis L. Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry. Procedia Vaccinol 2012;6:85-92.